Il-Yang Pharmaceutical Co. Ltd.
Il-Yang Pharmaceutical Co. Ltd. operates in Diversified Metals & Mining.
Market Cap & Net Worth: Il-Yang Pharmaceutical Co. Ltd. (007570)
Il-Yang Pharmaceutical Co. Ltd. (KQ:007570) has a market capitalization of $85.27K (₩124.85 Million) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #41422 globally and #2283 in its home market, demonstrating a 6.10% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Il-Yang Pharmaceutical Co. Ltd.'s stock price ₩13050.00 by its total outstanding shares 9567 (9.57K).
Il-Yang Pharmaceutical Co. Ltd. Market Cap History: 2015 to 2025
Il-Yang Pharmaceutical Co. Ltd.'s market capitalization history from 2015 to 2025. Data shows change from $309.33K to $85.27K (-12.11% CAGR).
Il-Yang Pharmaceutical Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Il-Yang Pharmaceutical Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 007570 by Market Capitalization
Companies near Il-Yang Pharmaceutical Co. Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Il-Yang Pharmaceutical Co. Ltd. by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
Il-Yang Pharmaceutical Co. Ltd. Historical Marketcap From 2015 to 2025
Between 2015 and today, Il-Yang Pharmaceutical Co. Ltd.'s market cap moved from $309.33K to $ 85.27K, with a yearly change of -12.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ₩85.27K | +14.37% |
| 2024 | ₩74.55K | -27.09% |
| 2023 | ₩102.26K | -18.33% |
| 2022 | ₩125.20K | -30.49% |
| 2021 | ₩180.13K | -57.06% |
| 2020 | ₩419.52K | +192.37% |
| 2019 | ₩143.49K | -17.55% |
| 2018 | ₩174.03K | -28.66% |
| 2017 | ₩243.96K | -7.44% |
| 2016 | ₩263.58K | -14.79% |
| 2015 | ₩309.33K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Il-Yang Pharmaceutical Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $85.27K USD |
| MoneyControl | $85.27K USD |
| MarketWatch | $85.27K USD |
| marketcap.company | $85.27K USD |
| Reuters | $85.27K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.